Samrat Pharmachem informs about outcome of AGM

03 Oct 2022 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Samrat Pharmachem has informed that it submitting the summary of the proceedings of the 30th Annual General Meeting (AGM) of the members of the Company held on Friday, September 30, 2022 at 2.00 pm (IST) through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM') conducted by NSDL. Further pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has submitted the details regarding the voting results of the business transacted at the AGM in the prescribed format. The business mentioned in the Notice dated May 30, 2022 was transacted. The Company has also enclosed the consolidated report of the Scrutinizer on e-voting and e-voting at the AGM. The above are being uploaded on the Company’s website ‘www.samratpharmachem.com’.

The above information is a part of company’s filings submitted to BSE.

Samrat Pharmachem Share Price

361.00 -1.65 (-0.45%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.